Bookbinder, Mark

Abstract 44: The discovery of ARV-471, an orally bioavailable estrogen receptor degrading PROTAC for the treatment of patients with breast cancer

Snyder, L. B., Flanagan, J. J., Qian, Y., Gough, S. M., Andreoli, M., Bookbinder, M., Cadelina, G., Bradley, J., Rousseau, E., Chandler, J., et al. (2021) · Cancer Research

Protein Degradation and InhibitorsEstrogen and related hormone effects

Cited by 126

Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning

Weed, M. R., Polino, J., Signor, L., Bookbinder, M., Keavy, D., Benitex, Y., Morgan, D. G., King, D., Macor, J. E., Zaczek, R., et al. (2017) · PLOS ONE

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 13